The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

COVID-19 is associated with long-term risk for autoimmune and ... there is currently no cure. SLE can be fatal, although with recent medical advances, fatalities are becoming increasingly rare.

In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).

XGN also received conditional approval from the New York State Department of Health for its new systemic lupus erythematosus ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...

However, their role in ensuring long-term immunity or offering an advantage against future infections remains to be clarified. Systemic Lupus Erythematosus (SLE)—lupus for short—is a chronic ...

However, their role in ensuring long-term immunity or offering an advantage against future infections remains to be clarified. Systemic Lupus Erythematosus (SLE)-lupus for short-is a chronic ...

1 Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical ... regional and country-specific estimates of epidemiology of systemic lupus erythematosus (SLE). Methods Four ...

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.